Jyothy Labs Raises Buyback Price To ₹240 Per Share, Reduces Share Count To 61,25,000

Market snapshot: Jyothy Labs Limited has revised its equity buyback offer terms via a tender offer route. The Buyback Committee approved increasing the buyback price to ₹240 per share from ₹215 per share while proportionally lowering the maximum number of equity shares to be repurchased to 61.25 lakh shares.

Data Snapshot

• Buyback offer price increased to ₹240 per share from the earlier approved price of ₹215 per share.
• Maximum buyback volume reduced to 61.25 lakh equity shares from the initial 68.37 lakh equity shares.
• Record date for determining eligible shareholders for participation in the buyback offer fixed as November 11, 2026.
• Total buyback offer size capped at ₹147 crore (derived: 61.25 lakh shares × ₹240 per share).

What's Changed

• Buyback price revised upwards to ₹240 per share from ₹215 per share (≈11.63% increase).
• Maximum shares eligible for buyback trimmed to 61.25 lakh shares from 68.37 lakh shares (≈10.42% reduction).

Key Takeaways

• Management increased the tender offer price to ₹240 per share to make the buyback offer more attractive to retail and institutional equity holders.
• The total financial outlay for the buyback remains unchanged at approximately ₹147 crore.
• Eligible shareholders identified as of the record date of November 11, 2026 can participate via the tender offer route.

SAHI Perspective

The upward revision in the buyback price signals management confidence and provides a higher payout per share to tendering shareholders. By maintaining the overall buyback size cap of ₹147 crore while reducing share count, Jyothy Labs optimizes cash utilization without expanding its capital commitment.

Market Implications

An increased tender price improves short-term downside protection for the stock around the record date of November 11, 2026. Tendering arbitrage efficiency will depend on the final acceptance ratio once eligible retail shareholders submit their shares.

Trading Signals

Market Bias: Bullish

The revision of buyback price to ₹240 per share from ₹215 per share increases the cash payout premium for shareholders while preserving the balance sheet budget at ₹147 crore.

Overweight: FMCG

Trigger Factors:

• Tender participation ratio updates post record date of November 11, 2026.
• Quarterly earnings momentum in personal care and fabric care segments.

Time Horizon: Near-term (0-3 months)

Industry Context

Capital return programs such as share repurchases via tender offer are frequently deployed by cash-generative FMCG businesses to return surplus cash to shareholders and enhance return on equity.

Key Risks to Watch

• Acceptance ratio risk for shareholders tendering excess shares above their entitlement ratio.
• General market volatility impacting share price post record date.

Recent Developments

On November 4, 2026, the Board of Directors of Jyothy Labs approved a tender offer buyback of up to 68,37,210 shares at ₹215 per share totaling ₹147 crore, with the record date subsequently fixed as November 11, 2026. On November 9, 2026, the Buyback Committee revised the price to ₹240 per share and maximum shares to 61,25,000.

Closing Insight

The increase in buyback price to ₹240 per share enhances immediate value realization for participating investors ahead of the November 11, 2026 record date.

High Performance Trading with SAHI.